Vistagen Therapeutics, Inc.
VTGNCIK 0001411685 · Every Form 4 filed by insiders at this issuer.
Filings
8
Latest Mar 6, 2024
Unique insiders
8
Showing
8 of 8
Page 1
Top insiders
Most active reporters at Vistagen Therapeutics, Inc.
| Name | Roles | Filings |
|---|---|---|
| Adler Reid G. | Officer | 1 |
| Cunningham Ann Michelle | Director | 1 |
| Curley Joanne | Director | 1 |
| FitzPatrick Margaret M | Director | 1 |
| GIN JERRY B | Director | 1 |
| Rotunno Mary L. | Director | 1 |
| SAXE JON S | Director | 1 |
| Singh Shawn | OfficerDirector | 1 |
All filings
8 Form 4 / 4-A filings, newest first
| Filed | Insider | Top transaction | Shares | Price | Value | |
|---|---|---|---|---|---|---|
| Mar 6, 2024 | SAXE JON S Director | Holdings only | — | — | — | |
| Mar 6, 2024 | Cunningham Ann Michelle Director | Holdings only | — | — | — | |
| Mar 6, 2024 | Curley Joanne Director | Holdings only | — | — | — | |
| Mar 6, 2024 | FitzPatrick Margaret M Director | Holdings only | — | — | — | |
| Mar 6, 2024 | GIN JERRY B Director | Holdings only | — | — | — | |
| Mar 6, 2024 | Rotunno Mary L. Director | Holdings only | — | — | — | |
| Jan 3, 2024 | Singh Shawn CHIEF EXECUTIVE OFFICER · Director | A | 167 | $1.717 | $287 | |
| Jan 3, 2024 | Adler Reid G. CHF CORP DEVEL OFF, GEN COUNS | A | 167 | $1.717 | $287 |
Showing 1–8 of 8
Page 1 of 1
Real-time Form 4 intelligence. Smarter insider tracking.